InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Fu Wei, Executive. Director active across 1 company, notably Everest Medicines Ltd.. In total, 9 filings have been logged. History available since 27 March 2026. The latest transaction was filed on 17 June 2026 (Purchase). Regulator: HKEX. All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
FU WEI is an executive at Everest Medicines Ltd. He oversees the company's operations, which specializes in developing innovative medicines. His expertise is crucial for the company's research and development strategy.